Aquestive Therapeutics Inc.
AQST | NASDAQ
$4.98
+$0.20 (+4.18%)
Sep 22, 2026, 12:57 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -78.23M | -68.91M | -83.78M | -68.98M | -65.04M | -54.24M | -44.14M | -35.19M | -25.72M | -28.77M | -7.87M | -12.11M | -22.61M | -33.12M | -54.41M | -71M | -73.02M | -69.09M | -70.54M | -61.96M | -63.96M | -53.92M |
Depreciation & Amortization | 518K | 522K | 548K | 565K | 585K | 650K | 718K | 1.04M | 1.14M | 1.23M | 1.34M | 1.27M | 1.61M | 1.99M | 2.39M | 2.72M | 2.86M | 2.94M | 2.96M | 3.51M | 4.02M | 4.66M |
Stock-Based Compensation | 9.37M | 8.36M | 7.62M | 8.65M | 7.45M | 7.11M | 7.1M | 5.64M | 4.83M | 3.93M | 2.69M | 2.46M | 2.22M | 3.81M | 4.38M | 5.36M | 6.72M | 6.23M | 6.82M | 5.13M | 4.99M | 5.04M |
Other Working Capital | 921K | 2.36M | 3.16M | -1.63M | -3.92M | -15.89M | -15.79M | -15.58M | -13.16M | -4.56M | -838K | 13.44M | 18.49M | 22.56M | 24.77M | 11.41M | 9.19M | 6.83M | 4.23M | 3.27M | 1.51M | -6.83M |
Other Non-Cash Items | 22.21M | 11.41M | 11M | 10.98M | 10.94M | 10.61M | 10.52M | 13.18M | 10.54M | 8.24M | 5.33M | -118K | 2.02M | 3.87M | 5.85M | 21.59M | 24.19M | 26.63M | 29.51M | 18.09M | 14.51M | 9.32M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.53M | -2.53M | -2.53M | -2.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 768K | 4.79M | 12.18M | -1.67M | -3.62M | -12.9M | -9.96M | -16.34M | -12.95M | -7.67M | -5.34M | 15.5M | 28.92M | 36.97M | 32.01M | 15.03M | 1.08M | -68K | -1.73M | -3.2M | 2.75M | -11.01M |
Operating Cash Flow | -45.37M | -43.84M | -52.43M | -50.45M | -49.68M | -48.78M | -35.76M | -34.21M | -24.68M | -25.58M | -6.38M | 7.01M | 12.16M | 13.51M | -9.79M | -26.3M | -38.17M | -33.36M | -32.98M | -38.43M | -37.68M | -45.92M |
Capital Expenditures | -584K | -479K | -562K | -492K | -337K | -265K | -159K | -160K | -231K | -1.02M | -995K | -1.01M | -2.57M | -2.42M | -2.52M | -3.03M | -1.4M | -914K | -913K | -616K | -571K | -489K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -584K | -479K | -562K | -492K | -337K | -265K | -159K | -160K | -231K | -1.02M | -995K | -1.01M | -2.57M | -2.42M | -2.52M | -3.03M | -1.4M | -914K | -913K | -616K | -571K | -489K |
Debt Repayment | 9.33M | -28K | -31K | -31K | -32K | -29K | -23K | -39M | -37.97M | -42.45M | -51.53M | -13.22M | -13.57M | -9.76M | -675K | n/a | -675K | n/a | n/a | 22.34M | 22.34M | 22.34M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -59K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -10.6M | 1.38M | 1.01M | 1.22M | -677K | -684K | -335K | 38.73M | 42.7M | 47.27M | 46.59M | 1.48M | -3.65M | -2.35M | -1.32M | 4.8M | 6.15M | 329K | 329K | 60K | 69K | 59K |
Financial Cash Flow | 83.9M | 86.39M | 102.62M | 102.11M | 20.69M | 22.5M | 83.59M | 87.35M | 92.34M | 94.92M | 3.97M | 265K | -4.85M | 1.06M | 11.56M | 16.81M | 23.03M | 21.52M | 30.11M | 53.15M | 47.06M | 38.39M |
Net Cash Flow | 37.95M | 42.08M | 49.62M | 51.17M | -29.33M | -26.54M | 47.67M | 52.98M | 67.43M | 68.32M | -3.4M | 6.27M | 4.74M | 12.15M | -751K | -12.52M | -16.54M | -12.76M | -3.78M | 14.1M | 8.81M | -8.02M |
Free Cash Flow | -45.95M | -44.32M | -52.99M | -50.94M | -50.02M | -49.04M | -35.92M | -34.37M | -24.91M | -26.6M | -7.38M | 6M | 9.59M | 11.09M | -12.31M | -29.33M | -39.57M | -34.28M | -33.89M | -39.05M | -38.25M | -46.41M |
Adj. Free Cash Flow | -55.32M | -52.67M | -60.62M | -59.6M | -57.47M | -56.15M | -43.02M | -40.01M | -29.74M | -30.53M | -10.06M | 3.54M | 7.37M | 7.28M | -16.69M | -34.69M | -46.29M | -40.5M | -40.71M | -44.17M | -43.24M | -51.45M |
Maintenance CapEx | -423K | -394K | -477K | -492K | -257K | -150K | -15K | n/a | n/a | -826K | -828K | -854K | -2.57M | -2.42M | -2.42M | -2.39M | -677K | -194K | -194K | -430K | -468K | -274K |
Growth CapEx | -161K | -85K | -85K | n/a | -80K | -115K | -144K | -160K | -231K | -196K | -167K | -151K | n/a | n/a | -104K | -637K | -720K | -720K | -719K | -186K | -103K | -215K |
Owner Earnings | -45.79M | -44.23M | -52.91M | -50.94M | -49.94M | -48.93M | -35.77M | -34.21M | -24.68M | -26.41M | -7.21M | 6.15M | 9.59M | 11.09M | -12.21M | -28.69M | -38.85M | -33.56M | -33.17M | -38.86M | -38.15M | -46.19M |
Add to Watchlist
Select watchlists to add or remove AQST